C CANCER RESEARCH HORIZONS
LIVE

Serial Number

79357872

Owner

Cancer Research Technology Limited

Attorney

David J. Hrina

Filing Date

Jul 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

C CANCER RESEARCH HORIZONS Trademark

Serial Number: 79357872 • Registration: 7256888

C CANCER RESEARCH HORIZONS is a trademark filed by Cancer Research Technology Limited on July 5, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Cancer Research Technology Limited (5 trademarks)

2 Redman Place

Entity Type: 99

Trademark Details

Filing Date

July 5, 2022

Registration Date

January 2, 2024

Published for Opposition

October 17, 2023

Goods & Services

Chemicals for use in the pharmaceutical research, development or manufacturing industry; chemical preparations for use in the manufacture of pharmaceuticals; cultures of cell media for scientific and research use; media for cell culture for laboratory use in the biotechnological industry; media for cell culture for use in non-medical research laboratories; media for cell culture for use in medical research laboratories

Medical apparatus and instruments, namely for the diagnosis, prevention or treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for the diagnosis or prevention of cancer

Organisation of community sporting and cultural events; arranging and conducting of conferences and seminars in the field of cancer prevention, diagnosis and treatment; education services, namely courses, seminars, workshops and conferences featuring subject matter related to alleviation, diagnosis, prevention and treatment of cancer; the publication of books, texts and magazines; developing and conducting educational programs in the fields of health, diet, nutrition, cancer and cancer prevention

Pharmaceutical products for the diagnosis, prevention or treatment of cancer; cultures of cell media for medical and veterinary use; living cells for medical or veterinary use

Scientific and medical research services; providing medical and scientific research information relating to alleviation, diagnosis, prevention and treatment of cancer; Conducting research in the fields of health, diet, nutrition, cancer and cancer prevention; conducting clinical trials for others in the field of oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biomedical research services; laboratory research services relating to cancer and diagnosis, prevention or treatment thereof; medical research in the field of oncology; scientific advisory services relating to chemical reagents; scientific advisory services relating to biological reagents; Clinical or medical laboratory services relating to the production of monoclonal antibodies; laboratory research in the field of gene expression

Charitable fundraising; Charitable collections in the nature of charitable fundraising; Organisation of charitable collections in the nature of charitable fundraising; charitable fundraising services by means of organisation of fundraising activities and events to support cancer research; providing financial grants for the purpose of research, diagnosis, treatment and prevention of cancer

Licensing of intellectual property; licensing of intellectual property for use in the treatment of cancer

promotion and advertising of products and services for others for the treatment of cancer; marketing of products and services for others for the treatment of cancer; business project management; business intermediary services in the nature of connecting buyers and sellers for the sale and purchase of goods and services for the treatment of cancer; business information services; providing an on-line commercial information directory for products and services for the treatment of cancer; providing advertising information featuring goods and services of others for the treatment of cancer via an on-line searchable database; business advisory services relating to the commercialisation of products and services for the treatment of cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 18, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 30, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 9, 2024 FICS
FINAL DISPOSITION PROCESSED
Apr 9, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 2, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 2, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Oct 17, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 27, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 27, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 8, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 8, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 8, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 8, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 28, 2023 TROA
REFUSAL PROCESSED BY IB
Jul 4, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 10, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 10, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 26, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 25, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 19, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 23, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 19, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 17, 2022 REPR